TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 394 filers reported holding TANDEM DIABETES CARE INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8 | -11.1% | 371 | 0.0% | 0.00% | – |
Q2 2023 | $9 | -55.0% | 371 | -25.1% | 0.00% | -100.0% |
Q1 2023 | $20 | -31.0% | 495 | -22.9% | 0.00% | -50.0% |
Q4 2022 | $29 | -99.9% | 642 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $31,000 | -39.2% | 642 | -25.6% | 0.00% | -33.3% |
Q2 2022 | $51,000 | -70.9% | 863 | -42.7% | 0.00% | -62.5% |
Q1 2022 | $175,000 | +80.4% | 1,506 | +134.6% | 0.01% | +100.0% |
Q4 2021 | $97,000 | +26.0% | 642 | 0.0% | 0.00% | +33.3% |
Q3 2021 | $77,000 | -71.3% | 642 | -76.7% | 0.00% | -75.0% |
Q2 2021 | $268,000 | +7.2% | 2,757 | -2.8% | 0.01% | -7.7% |
Q1 2021 | $250,000 | -11.0% | 2,836 | -3.2% | 0.01% | -18.8% |
Q4 2020 | $281,000 | -10.2% | 2,929 | +5.9% | 0.02% | -20.0% |
Q3 2020 | $313,000 | +99.4% | 2,765 | +73.9% | 0.02% | +81.8% |
Q2 2020 | $157,000 | -42.5% | 1,590 | -62.6% | 0.01% | -52.2% |
Q1 2020 | $273,000 | -23.5% | 4,246 | -29.1% | 0.02% | -4.2% |
Q4 2019 | $357,000 | – | 5,985 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 1,000,000 | $59,610,000 | 47.04% |
Prospect Capital Advisors, LLC | 127,900 | $7,624,000 | 4.68% |
Asymmetry Capital Management, L.P. | 43,559 | $2,597,000 | 4.66% |
Copernicus Capital Management, LLC | 50,000 | $2,981,000 | 3.91% |
SECTORAL ASSET MANAGEMENT INC | 341,714 | $20,370,000 | 3.04% |
FRIESS ASSOCIATES LLC | 627,225 | $37,389,000 | 2.60% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,361,345 | $81,150,000 | 2.59% |
Parkman Healthcare Partners LLC | 134,959 | $8,045,000 | 2.32% |
OBERWEIS ASSET MANAGEMENT INC/ | 109,940 | $6,554,000 | 2.18% |
First Light Asset Management, LLC | 268,574 | $16,010,000 | 2.05% |